GL1X · GenesisL1 explorer

Research workbench

SARS-cov-2 receptor-binding domain speedesign immunogen 1 bound to C144 scfv

Analyse SARS-cov-2 receptor-binding domain speedesign immunogen 1 bound to C144 scfv in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
8DCE
Type
protein
Length
436 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
C144 scfv; Spike protein S1
UniProt
P0DTC2
Pockets
2 · best druggability 0.59

Structure

x-ray diffraction · 2 distinct chains · 10% helix, 40% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
HC144 scfvprotein2424% helix, 47% strand—
ASpike protein S1protein19418% helix, 31% strandP0DTC2

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13760.590.7644empty
21150.370.7429empty

Interfaces

1 interface between chains.

  • H–A · 844 Ų buried · 23 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 6 disulfide (disulfide).

Compared structures

  • 8DCE · SARS-CoV-2 Receptor-Binding Domain SPEEDesign Immunogen 1 Bound to C144 scFv · the same entry in another collection · chain H against H, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.